Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TWi BiotechnologyROCO:6610 +0.37%34 Quick Ratio is 2.98 as of Dec. 2025, which is 55% below its 10-year median of 6.59. GuruFocus rates ROCO:6610 with a GF Score™ of 34/100. The stock has 2 warning signs investors should review. Among 1,411 Biotechnology companies, TWi Biotechnology ranks worse than 55.71% on this metric.
TWi Biotechnology has a quick ratio of 2.98. It generally indicates good short-term financial strength.
The historical rank and industry rank for TWi Biotechnology's Quick Ratio or its related term are showing as below:
ROCO:6610'
s Quick Ratio Range Over the Past 10 Years
Min: 2.5 Med: 6.59 Max: 18.32
Current: 2.98
During the past 13 years, TWi Biotechnology's highest Quick Ratio was 18.32. The lowest was 2.50. And the median was 6.59.
ROCO:6610's Quick Ratio is ranked worse than 55.71% of 1411
companies
in the Biotechnology industry
Industry Median: 3.59
vs ROCO:6610: 2.98
TWi Biotechnology (ROCO:6610) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
TWi Biotechnology Quick Ratio Related Terms
TWi Biotechnology Quick Ratio Historical Data
* Premium members only.
The historical data trend for TWi Biotechnology's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6610 vs VRTX, REGN, ALNY: Quick Ratio Comparison
For the Biotechnology subindustry, TWi Biotechnology's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TWi Biotechnology Quick Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, TWi Biotechnology's Quick Ratio distribution charts can be found below:
* The bar in red indicates where TWi Biotechnology's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
TWi Biotechnology's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TWi Biotechnology (ROCO:6610) has a Quick Ratio of 2.98 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on TWi Biotechnology and its competitors. This is 55% below median its historical median of 6.59. Over the past decade, TWi Biotechnology's Quick Ratio has ranged from 2.50 to 18.32. According to the industry distribution chart, TWi Biotechnology ranks #786 out of 1411 companies in the Biotechnology industry, placing it in the top 55.7%.
Is TWi Biotechnology's Quick Ratio too high?
TWi Biotechnology's current Quick Ratio of 2.98 is 55% below median its 10-year median of 6.59. Over the past 10 years, this metric has ranged from a low of 2.50 to a high of 18.32. The Biotechnology industry median Quick Ratio is 3.59. TWi Biotechnology's value of 2.98 is 17% below this industry median. Based on the distribution chart, TWi Biotechnology ranks #786 out of 1411 companies in the Biotechnology industry, which is below the industry midpoint. Overall, TWi Biotechnology has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does TWi Biotechnology's Quick Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, TWi Biotechnology ranks #786 out of 1411 companies for Quick Ratio. This places TWi Biotechnology in the lower half of its industry. The industry median Quick Ratio is 3.59. TWi Biotechnology's value of 2.98 is 17% below this benchmark. Historically, TWi Biotechnology's own Quick Ratio has ranged from 2.50 to 18.32 over the past decade. While the company's 10-year median is 6.59 vs. the industry median of 3.59, TWi Biotechnology has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Biotechnology company?
The median Quick Ratio among Biotechnology companies is 3.59, based on 1,411 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TWi Biotechnology's current Quick Ratio of 2.98 is 17% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on TWi Biotechnology and its competitors. For the Biotechnology industry, the median Quick Ratio is 3.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TWi Biotechnology's current Quick Ratio is 2.98, which is 55% below median its own 10-year median of 6.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TWi Biotechnology stock overvalued right now?
TWi Biotechnology (ROCO:6610) has a current Quick Ratio of 2.98. The current Quick Ratio is 2.98, which is 55% below median its 10-year median of 6.59 and 17% below the Biotechnology industry median of 3.59. TWi Biotechnology's overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For TWi Biotechnology (ROCO:6610), the current Quick Ratio is 2.98 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
TWi Biotechnology Inc is a clinical-stage biopharmaceutical company based in Taiwan. It is engaged in the development of new drugs for unmet medical needs, particularly in the diseases associated with innate immunity. The pipeline products of the company comprise AC-201, AC-203, and AC-701.
34GF Score
Get the complete analysis for ROCO:6610
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6610 has been successfully added to your 
